slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 32,371-32,400
Pages 1,379
Rows per page 30
Component
32,371-32,400 of 41,369
18
Clinical trial data presentation with statistical significance markers and MCID thresholds.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
19
The slide uses a heatmap to display individual patient outcomes across four metrics (pArg, GMFM-E, 2MWT, GMFM-D).Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
20
The slide presents clinical trial safety data comparing Pegzilarginase to a placebo group.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Traction1 hit
25
The slide uses a biological pathway diagram to explain the mechanism of action of the drug candidate.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · TractionLoop · Before After1 hit
05
Allbirds | Investor Presentation Deck | 13 slidesAllbirds | Investor Presentation Deck | 13 slides · Allbirds
Conference presentation Investor relations Loop · Why Now1 hit
08
The slide uses a waterfall-like progression to show growth from existing to pipeline.Allego | Results Presentation Deck | 17 slides · Allego
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
06
Includes a 'click to learn more' interactive element, likely from a digital presentation deck.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
09
The slide uses a color-coded column layout to present performance metrics for different investment strategies.Apollo Global Management | Investor Presentation Deck | 43 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
20
The slide uses a three-column layout to highlight key value propositions.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
22
Includes a disclaimer at the bottom regarding an FDA clinical hold.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
23
The slide uses two distinct chart types (dose-response curve and bar chart) to show efficacy in two different biological assays.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
25
The slide uses a biological map of the coronavirus genome to justify targeting nsp5 and nsp12.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
26
The slide highlights key therapeutic advantages of the candidate drug.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
06
The slide uses a visual representation of an antibody to explain the mechanism of action (sweeping antibody, pH/Ca2+ switch, no effector function).argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · What Could BeLoop · Aha Moment1 hit
07
Includes a biological mechanism diagram on the left and a clinical trial roadmap on the right.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
09
The slide highlights a significant reduction in operating loss and net loss compared to the prior year period.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
12
The slide uses a geographic split between US and Global markets to track regulatory milestones.argenx SE | Results Presentation Deck | 13 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Why Now1 hit
09
Asos | Results Presentation Deck | 36 slidesAsos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
10
Asos | Results Presentation Deck | 36 slidesAsos | Results Presentation Deck | 36 slides · Asos
Conference presentation Investor relations 1 hit
04
The slide uses a hierarchical structure to connect a high-level objective to three specific strategic pillars.ATAI | Investor Conference Presentation Deck | 14 slides · atai Life Sciences
Conference presentation Investor relations Beat · Solution1 hit
08
The slide uses a bar chart to show T-scores across three cognitive tests (HVLT, Symbol Coding, Category Fluency) at different dosage levels.ATAI | Investor Conference Presentation Deck | 14 slides · atai Life Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
09
The slide outlines a standard randomized controlled trial (RCT) flow.ATAI | Investor Conference Presentation Deck | 14 slides · atai Life Sciences
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
05
Uses a value chain comparison to illustrate market inefficiency vs. Azerion's one-stop shop model.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
13
The slide categorizes reach into three segments: Non-game content (>400m), Game content (>100m), and E-commerce.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations Beat · Traction1 hit
24
The slide uses a value-chain style diagram to map the flow from advertisers to consumers through the company's proprietary technology stack.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations 1 hit
25
Uses a value chain comparison to illustrate market fragmentation vs. Azerion's one-stop shop model.Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations 1 hit
27
The slide highlights the synergy between a content aggregator (Genba) and a storefront (Voidu).Azerion | Investor Presentation Deck | 32 slides · Azerion
Pitch deck Investor relations 1 hit
17
Includes a callout highlighting no debt maturities until 2025 for specific segments.Bausch Health Companies | Results Presentation Deck | 40 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit
18
The chart includes a callout box summarizing total debt, restricted vs. unrestricted portions, and a recent reduction in restricted debt.Bausch Health Companies | Results Presentation Deck | 40 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit
20
Includes detailed footnotes regarding non-GAAP measures and specific accounting adjustments.Bausch Health Companies | Results Presentation Deck | 40 slides · Bausch Health
Conference presentation Investor relations Beat · Visualization1 hit